Clinical Trial Update: DAOIB for the Treatment of Mild Cognitive Impairment [Phase 2]

View source ↗

Summary

Clinical trial update indicates completion of a Phase 2 study of DAOIB for mild cognitive impairment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Drugs mentioned

• DAOIB

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Mild Cognitive Impairment | Phase 2 | Status: COMPLETED